Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus Infections

Explore clinical trials studying Respiratory Syncytial Virus Infections. Study availability and eligibility vary by location and protocol.

248 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus Infections trial results

Completed

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

NCT06134648

Conditions
Healthy Volunteers, Human Metapneumovirus, Infections, +7 more
Locations
  • Collaborative Neuroscience Research Site Number : 8400017 Los Alamitos, California, United States
  • Matrix Clinical Research Site Number : 8400011 Los Angeles, California, United States
  • Peninsula Research Associates Site Number : 8400001 Rolling Hills Estates, California, United States
  • Suncoast Research Associates, LLC Site Number : 8400002 Miami, Florida, United States
View all 13 locations
View Trial Details
Completed

Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

NCT06251024

Conditions
Healthy Volunteers, Infections, Mononegavirales Infections, +6 more
Locations
  • Investigational Site Number : 0360003 Botany, New South Wales, Australia
  • Investigational Site Number : 0360004 Sippy Downs, Queensland, Australia
  • Investigational Site Number : 0360001 Southport, Queensland, Australia
  • Investigational Site Number : 0360002 Camberwell, Victoria, Australia
View all 25 locations
View Trial Details
Completed

A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

NCT06083623

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Children's Hospital Capital Institute Pediatrics Beijing, Beijing Municipality, China
  • Jiangjin Central Hospital Chongqing, Chongqing Municipality, China
  • Xiamen maternal and Child Health Hospital Xiamen, Fujian, China
View all 39 locations
View Trial Details
Completed

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

NCT04767373

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Southeastern Pediatric Associates, P.A. ( Site 0008) Dothan, Alabama, United States
  • Northwest Arkansas Pediatric Clinic ( Site 0050) Fayetteville, Arkansas, United States
  • Children's Clinic of Jonesboro, PA ( Site 0058) Jonesboro, Arkansas, United States
  • Long Beach Memorial Medical Center ( Site 0014) Long Beach, California, United States
View all 217 locations
View Trial Details
Completed

Real-World Effectiveness of Nirsevimab Against RSV-Related and All-Cause Respiratory Tract Infections in Chinese Infants

NCT07382219

Conditions
Infections, Lower Respiratory Tract Infections, Mononegavirales Infections, +6 more
Locations
  • Inner Mongolia Maternity and Child Health Care Hospital Hohhot, Inner Mongolia, China
  • Women and Children's Hospital Qingdao, Shandong, China
  • Beijing Children's Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View Trial Details
Completed

Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)

NCT05687279

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Meridian Clinical Research Norfolk Site Number : 8400003 Norfolk, Nebraska, United States
  • Velocity Clinical Research, Omaha Site Number : 8400001 Omaha, Nebraska, United States
  • Investigational Site Number : 6300004 Bayamón, Puerto Rico
  • Investigational Site Number : 6300002 Carolina, Puerto Rico
View Trial Details
Completed

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

NCT06374394

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Coral Gables, Florida, United States
  • GSK Investigational Site Savannah, Georgia, United States
  • GSK Investigational Site Evansville, Indiana, United States
  • GSK Investigational Site Omaha, Nebraska, United States
View all 24 locations
View Trial Details

Related conditions